Regis Healthcare Valuation
| REG Stock | 6.72 0.16 2.44% |
At this time, the company appears to be fairly valued. Regis Healthcare holds a recent Real Value of USD6.42 per share. The prevailing price of the company is USD6.72. Our model determines the value of Regis Healthcare from analyzing the company fundamentals such as Operating Margin of 0.06 %, return on equity of -2.76, and Shares Outstanding of 301.25 M as well as examining its technical indicators and probability of bankruptcy.
Price Book 259.3431 | Enterprise Value 1.8 B | Enterprise Value Ebitda 8.2078 | Price Sales 1.8339 | Forward PE 29.0698 |
Fairly Valued
Today
Please note that Regis Healthcare's price fluctuation is somewhat reliable at this time. Calculation of the real value of Regis Healthcare is based on 3 months time horizon. Increasing Regis Healthcare's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Regis Healthcare's intrinsic value may or may not be the same as its current market price of 6.72, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 6.72 | Real 6.42 | Hype 6.55 | Naive 6.65 |
The intrinsic value of Regis Healthcare's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Regis Healthcare's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Regis Healthcare helps investors to forecast how Regis stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Regis Healthcare more accurately as focusing exclusively on Regis Healthcare's fundamentals will not take into account other important factors: Regis Healthcare Cash |
|
Regis Healthcare Total Value Analysis
Regis Healthcare is at this time forecasted to have takeover price of 1.8 B with market capitalization of 2.01 B, debt of 3.84 M, and cash on hands of 4.15 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Regis Healthcare fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
1.8 B | 2.01 B | 3.84 M | 4.15 M |
Regis Healthcare Investor Information
About 51.0% of the company outstanding shares are owned by corporate insiders. The company has Price/Earnings To Growth (PEG) ratio of 1.62. Regis Healthcare last dividend was issued on the 13th of March 2025. Based on the measurements of operating efficiency obtained from Regis Healthcare's historical financial statements, Regis Healthcare is performing exceptionally good at this time. It has a great probability to report excellent financial results in April.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Total Cash From Operating Activities | 147 M | 290.1 M |
|
|
Regis Healthcare Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The newest return on assets of Regis implies not a very effective usage of assets in March.Regis Healthcare Ownership Allocation
Regis Healthcare owns a total of 301.25 Million outstanding shares. Regis Healthcare has significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.Regis Healthcare Profitability Analysis
The company reported the revenue of 1.01 B. Net Loss for the year was (21.41 M) with profit before overhead, payroll, taxes, and interest of 195.43 M.About Regis Healthcare Valuation
The stock valuation mechanism determines Regis Healthcare's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Regis Healthcare based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Regis Healthcare. We calculate exposure to Regis Healthcare's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Regis Healthcare's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 157.7 M | 93.4 M |
Additional Tools for Regis Stock Analysis
When running Regis Healthcare's price analysis, check to measure Regis Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Regis Healthcare is operating at the current time. Most of Regis Healthcare's value examination focuses on studying past and present price action to predict the probability of Regis Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Regis Healthcare's price. Additionally, you may evaluate how the addition of Regis Healthcare to your portfolios can decrease your overall portfolio volatility.